Crossmark

Reamputation risk and mortality after lower-limb amputation in patients with diabetes: predictors, effects of antidiabetic medications and temporal trends

Crossref DOI link: https://doi.org/10.1186/s12933-026-03145-9

Published Online: 2026-03-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Radlinger, Bernhard

Blasinger, Jana

Köllenberger, Nicolas

Streitberger, Verena

Kopp, Lena

Bifano, Elena

Landolfo, Matteo

Aziz, Faisal

Sourij, Harald

Göbel, Georg

Klocker, Josef

Kaser, Susanne
License Information

Text and Data Mining valid from 2026-03-23

Version of Record valid from 2026-04-30
More Information

Article History

Received: 6 October 2025

Accepted: 9 March 2026

First Online: 23 March 2026

Declarations

:

: This study was approved by the local ethics committee of the Medical University of Innsbruck (Reference: 1108/2023). All study procedures complied with the Declaration of Helsinki.

: As no specific funding was collected for the conduction of this study, no potential conflict of interest can be reported from authors.

Document is current

Any future updates will be listed below